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Eﬀ ect of the plane of surgery achieved on local recurrence in 
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study using data from the MRC CR07 and NCIC-CTG CO16 
randomised clinical trial
Phil Quirke, Robert Steele, John Monson, Robert Grieve, Subhash Khanna, Jean Couture, Chris O’Callaghan, Arthur Sun Myint, Eric Bessell, 
Lindsay C Thompson, Mahesh Parmar, Richard J Stephens, David Sebag-Monteﬁ ore, on behalf of the MRC CR07/NCIC-CTG CO16 trial 
investigators and the NCRI colorectal cancer study group*
Summary
Background Local recurrence rates in operable rectal cancer are improved by radiotherapy (with or without 
chemotherapy) and surgical techniques such as total mesorectal excision. However, the contributions of surgery and 
radiotherapy to outcomes are unclear. We assessed the eﬀ ect of the involvement of the circumferential resection 
margin and the plane of surgery achieved. 
Methods In this prospective study, the plane of surgery achieved and the involvement of the circumferential resection 
margin were assessed by local pathologists, using a standard pathological protocol in 1156 patients with operable 
rectal cancer from the CR07 and NCIC-CTG CO16 trial, which compared short-course (5 days) preoperative 
radiotherapy and selective postoperative chemoradiotherapy, between March, 1998, and August, 2005. All analyses 
were by intention to treat. This trial is registered, number ISRCTN 28785842.
Findings 128 patients (11%) had involvement of the circumferential resection margin, and the plane of surgery 
achieved was classiﬁ ed as good (mesorectal) in 604 (52%), intermediate (intramesorectal) in 398 (34%), and poor 
(muscularis propria plane) in 154 (13%). We found that both a negative circumferential resection margin and a 
superior plane of surgery achieved were associated with low local recurrence rates. Hazard ratio (HR) was 0·32 
(95% CI 0·16–0·63, p=0·0011) with 3-year local recurrence rates of 6% (5–8%) and 17% (10–26%) for patients who 
were negative and positive for circumferential resection margin, respectively. For plane of surgery achieved, HRs 
for mesorectal and intramesorectal groups compared with the muscularis propria group were 0·32 (0·16–0·64) and 
0·48 (0·25–0·93), respectively. At 3 years, the estimated local recurrence rates were 4% (3–6%) for mesorectal, 
7% (5–11%) for intramesorectal, and 13% (8–21%) for muscularis propria groups. The beneﬁ t of short-course 
preoperative radiotherapy did not diﬀ er in the three plane of surgery groups (p=0·30 for trend). Patients in the 
short-course preoperative radiotherapy group who had a resection in the mesorectal plane had a 3-year local 
recurrence rate of only 1%. 
Interpretation In rectal cancer, the plane of surgery achieved is an important prognostic factor for local recurrence. 
Short-course preoperative radiotherapy reduced the rate of local recurrence for all three plane of surgery groups, 
almost abolishing local recurrence in short-course preoperative radiotherapy patients who had a resection in the 
mesorectal plane. The plane of surgery achieved should therefore be assessed and reported routinely.
Funding Medical Research Council (UK) and the National Cancer Institute of Canada. 
Introduction
Outcomes in operable rectal cancer show wide variation, 
with local recurrence ranging from less than 6% to more 
than 50% and survival from 45% to 80% at 5 years.1–3 Two 
methods for improving outcomes are preoperative 
radiotherapy4–7 (alone or in combination with chemo-
therapy) and better surgical techniques.8,9 For preoperative 
radiotherapy, both short-course treatment, as proposed 
by radiotherapists in Sweden,4–6 and long-course radio-
therapy or chemoradiotherapy10 improve local recurrence 
rates4–7,10 and overall survival.4,6 However, radiotherapy 
increases the cost of the management of these patients11 
and has well described long-term toxic eﬀ ects.12,13
Surgical training, including total mesorectal 
excision, also reduced local recurrence rates and 
improved survival in populations from Norway,14 
Sweden,15 and Netherlands.16 Removed resection 
specimens diﬀ er in their appearance, and macroscopic 
grading might be a way to assess and classify the plane 
of surgery achieved.9 A study17 of 180 cases that adopted 
this grading showed that surgery in the mesorectal plane 
lowered local recurrence rates and improved survival 
compared with other planes of surgery.
However, the plane of surgery achieved and its eﬀ ect 
on local recurrence rates have not been routinely assessed 
by local pathologists in large clinical trials. Furthermore, 
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the relative improvements in surgical techniques and 
radiotherapy are unclear. We prospectively assessed the 
importance of circumferential resection margin and the 
grading of the plane of surgery achieved from data 
obtained in the international multicentre CR07 and 
NCIC-CTG CO16 trial.
Our aim was to answer these key questions: does the 
data support the use of circumferential resection 
margin as a prognostic factor for local recurrence? Is 
the prospective histopathological assessment of the 
plane of surgery achieved an independent prognostic 
factor for local recurrence? Is the relative beneﬁ t of 
preoperative radiotherapy inversely related to the plane 
of surgery achieved (ie, does preoperative radiotherapy 
lead to greater beneﬁ t with poorer plane of surgery 
achieved)?
Methods
Procedures
The Medical Research Council (MRC) CR07 and 
NCIC-CTG CO16 trial is a large, international, 
multicentre randomised controlled trial, done between 
March, 1998, and August, 2005, that compared 5-day 
short-course preoperative radiotherapy with immediate 
surgery and reserving postoperative chemoradiotherapy 
for high-risk circumferential resection margin positive 
patients. We assessed a total of 1156 patients for plane 
of surgery achieved. This protocol was approved in the 
UK by the Multicentre Research Ethics Committee for 
Scotland. Local approval was obtained at all parti-
cipating institutions, and written informed consent was 
obtained from all patients. The MRC Clinical Trials 
Unit coordinated the trial in the UK and analysed 
the data. The National Cancer Institute of Canada 
Clinical Trials Group (NCIC-CTG), and one centre 
in South Africa and one in New Zealand also 
participated.
In this trial, local histopathologists assessed the 
resected specimen in two ways: by the tumour 
involvement of the surgical circumferential resection 
margin (an involved circumferential resection margin 
was deﬁ ned as tumour within or equal to 1 mm or less 
from the circumferential resection margin)18 and by the 
plane of surgery achieved by the surgeon. The trial 
protocol deﬁ ned the histopathological assessment. 
Training classes, where grading of the specimen, 
dissection, and reporting were demonstrated, were held 
for pathologists who were taking part in the study in 
the UK, Canada, and South Africa. We used a pathology 
proforma based on the TNM system version 5 to record 
data and other important pathological features, 
including site of tumour, completeness of excision, 
distance of extramural spread, distance to 
circumferential resection margin, extramural vascular 
invasion, and peritoneal invasion. The panel shows 
grading of the specimen to identify the plane of surgery 
achieved.
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Figure 1: Circumferential resection margin positivity rate during trial recruitment
Preoperative
radiotherapy (better)
0·1 0·2 0·5 1·0 2·0
Selective postoperative 
chemoradiotherapy (better)
Number of events/total number
Preoperative
radiotherapy
Selective postoperative 
chemoradiotherapy
Local recurrence
CRM +ve
CRM –ve
Muscularis propria
Intramesorectal
Mesorectal
Disease-free survival
CRM +ve
CRM –ve
Muscularis propria
Intramesorectal
Mesorectal
4/56
15/500
5/65
9/196
5/303
25/56
94/500
19/65
48/196
54/303
10/72
48/513
14/89
18/202
27/301
37/72
124/513
26/89
52/202
85/301
p=0·27
p=0·30
p=0·34
p=0·19
HR (95% CI) Interaction p value
Figure 2: Eﬀ ect of treatment on circumferential resection margin and plane of surgery subgroups
CRM=circumferential resection margin. HR=hazard ratio. +ve=positive. –ve=negative.
Panel: Grading of specimen
Mesorectal plane (good plane of surgery achieved)
Intact mesorectum with only minor irregularities of a 
smooth mesorectal surface; no defect deeper than 5 mm; 
no coning; and smooth circumferential resection margin 
on slicing
Intramesorectal plane (moderate plane of surgery 
achieved)
Moderate bulk to mesorectum, with irregularities of the 
mesorectal surface; moderate distal coning; muscularis 
propria not visible with the exception of levator insertion; 
and moderate irregularities of circumferential resection 
margin
Muscularis propria plane (poor plane of surgery achieved)
Little bulk to mesorectum with defects down onto 
muscularis propria; very irregular circumferential resection 
margin; or both
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Outcome measures
We deﬁ ned local-recurrence-free interval as the time 
from randomisation to a conﬁ rmed local recurrence. 
Conﬁ rmation of local recurrence came from: positive 
biopsy, positive imaging, or positive carcinoembryonic 
antigen (if imaging was equivocal and there was no 
evidence of distant metastases). Patients without a 
conﬁ rmed local recurrence were censored at the time of 
last follow-up.
We deﬁ ned disease-free survival as the time from 
randomisation to the time of conﬁ rmed local recurrence, 
metastases, or death related to disease or treatment, 
whichever occurred ﬁ rst. Patients who were alive and 
disease-free, or died of other causes, were censored at the 
time of last follow-up.
Statistical analysis
All analyses were by intention to treat. We compared 
Kaplan-Meier curves of local-recurrence-free interval 
and disease-free survival with a two-sided log rank test. 
We compared proportions with the χ² test, and ordered 
categories with the Mann-Whitney test.
We used a logistic regression model to study the 
association between an involved circumferential 
resection margin and clinical, surgical, and pathological 
factors in a multivariate analysis. We used a Cox 
regression model with fractional polynomials to study 
the association between time to local recurrence and 
clinical, surgical, and pathological factors in a 
multivariate analysis to allow for possible non-linearity 
of any associations.19,20 In both multivariate analyses, all 
factors were forced into the model to allow the relative 
importance of individual factors to be assessed, taking 
into account all other factors.
Role of the funding source
The sponsor of the trial had no role in the design or 
conduct of the study, or analysis of the data. The 
corresponding author had full access to the data and had 
ﬁ nal responsibility for the decision to submit for 
publication.
Results
1350 patients were randomised (674 to short-course 
preoperative radiotherapy and 676 to selective 
postoperative chemoradiotherapy) from 80 centres 
(69 in UK, nine in Canada, one in South Africa, and one 
in New Zealand). Patient characteristics, treatment 
received, and overall results are described in the 
accompanying paper.21 Overall, the median age of 
patients was 65 years, 981 (73%) were male, 1069 (79%) 
were WHO performance status 0, and resection was 
done in 1237 (97%), with an anterior resection in 
792 (62%) and an abdominoperineal excision in 
404 (32%). Of the patients allocated to short-course 
preoperative radiotherapy, 614 (96%) received 25Gy/5f 
preoperative radiotherapy, and of those allocated to 
selective postoperative chemoradiotherapy who were 
reported as having a positive circumferential resection 
margin, 53 (69%) received postoperative chemo-
radiotherapy. 99 (7%) patients had a local recurrence. 
Short-course preoperative radiotherapy reduced the 
3-year local recurrence rate from 10·6% with selective 
postoperative chemo radiotherapy to 4·4% with 
short-course pre operative radiotherapy (hazard ratio 
[HR] 0·39, 95% CI 0·27–0·58, p<0·0001) and improved 
the 3-year disease-free survival from 71·5% with 
selective postoperative chemo radiotherapy to 77·5% 
with short-course preoperative radiotherapy (HR 0·76, 
95% CI 0·62–0·94, p=0·013), with only minor 
short-term morbidity.
Patients assessed for plane of surgery achieved were 
similar to the trial population. Of 1156 patients assessed 
(table 1), 835 (72%) were male, 930 (80%) were WHO 
performance status 0, anterior resection was done in 
700 (64%) and abdominoperineal excision in 356 (32%) 
and 78 (7%) patients have been reported as having had a 
local recurrence.
An involved circumferential resection margin occurred 
in 128 (11%) patients (10% with short-course preoperative 
radiotherapy and 12% with selective postoperative 
chemoradiotherapy). During the trial, the circumferential 
resection margin positivity rate decreased (p<0·001) 
(ﬁ gure 1) and the median distance from the tumour to 
the circumferential resection margin increased from 
5 mm in patients recruited in 1998–99 to 8 mm in those 
recruited in 2004–05 (p=0·038). Although this reduction 
was seen in patients who had an anterior resection (18% 
in 1998 and 8% in 2005), it was not seen in patients who 
had an abdominoperineal excision (17% in 1998 and 31% 
in 2005). An involved circumferential resection margin 
was associated with the surgical procedure 
(abdominoperineal excision: 16%; anterior resection: 
7%, p<0·0001), tumour position (distal extent 0–5 cm 
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Figure 3: Plane of surgery achieved during trial recruitment
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from the anal verge: 15%; 5·1–10 cm: 9%; 10·1–15 cm: 
9%, p=0·004), higher tumour (T) stage (p<0·0001) and 
nodal (N) stage (p<0·0001), and those tumours with an 
anterior component (involved: 13%; not involved: 7%, 
p=0·001). We showed, with a multivariate analysis 
including all the above factors, that T stage, 
N stage, and tumour position were independently 
associated with an involved circumferential resection 
margin.
Local recurrence rate and disease-free survival were 
diﬀ erent in patients who had a negative or positive 
circumferential resection margin (3-year local 
recurrence: 6% negative, 17% positive; HR 0·32, 
95% CI 0·16–0·63, p=0·0011; 3-year disease-free 
survival: 79% negative, 50% positive; HR 0·19, 
95% CI 0·13–0·28, p<0·0001).
Overall, patients allocated to short-course preoperative 
radiotherapy showed an improvement of local recurrence 
rate and disease-free survival. Although we showed that 
circumferential resection margin is a prognostic factor, 
there was no evidence that the beneﬁ t of short-course 
preoperative radiotherapy diﬀ ered with circumferen-
tial resection margin status. For local recurrence, the 
p value for the circumferential resection margin and 
treatment interaction was 0·27, and for disease-free 
survival 0·34. Figure 2 shows the eﬀ ect of short-course 
preoperative radiotherapy in the subgroups of 
circumferential resection margin.
Of the 1156 patients with pathological data available, 
surgery was achieved in the mesorectal plane in 
604 (52%), in the intramesorectal plane in 398 (34%), 
and in the muscularis propria plane in 154 (13%). The 
plane of surgery achieved improved over the course of 
the trial (ﬁ gure 3). Table 1 shows characteristics 
associated with the three planes of surgery. The plane of 
surgery achieved was worse in abdominoperineal 
excisions than in anterior resections (p<0·001), was 
related to circumferential resection margin positivity 
(p=0·001), but was not related to the TNM stage of 
tumour (p=0·68). There was no indication that the plane 
of surgery achieved was associated with the median 
lymph node yield (median yields: 11, 12, and 
12 for mesorectal plane, intramesorectal plane, and 
muscularis propria plane, respectively; p=0·71).
The plane of surgery achieved was strongly associated 
with local recurrence (ﬁ gures 2 and 4A), with a 3-year 
local recurrence rate of 4% (mesorectal plane), 
7% (intra mesorectal plane), and 13% (muscularis 
propria plane) (log rank p=0·0039). This pattern was 
repeated for 3-year disease-free survival (ﬁ gures 2 and 4B) 
(79% [mesorectal plane], 75% [intramesorectal plane], 
and 70% [muscularis propria plane]), although it did not 
reach statistical signiﬁ cance (log rank p=0·14).
The plane of surgery achieved was similar in the two 
treatment groups of the trial. The eﬀ ect of short-course 
preoperative radiotherapy did not diﬀ er with the plane of 
surgery achieved (p for trend=0·30; ﬁ gure 2). Local 
recurrence was almost abolished in patients who received 
short-course preoperative radiotherapy and in whom 
mesorectal plane surgery was achieved (1% at 3 years; 
table 2).
Analyses to investigate the association between plane 
of surgery achieved and circumferential resection 
margin status indicated that, for all three planes of 
surgery achieved, circumferential resection margin 
positive cases showed a higher rate of 3-year local 
recurrence (table 2 and ﬁ gure 5) and a decreased 3-year 
disease-free survival (table 3 and ﬁ gure 5) than did 
negative cases. 
Muscularis 
propria 
(n=154)
Intramesorectal 
(n=398)
Mesorectal 
(n=604)
Baseline factors
Sex
Male 109 (71%) 272 (68%) 454 (75%)
Female 45 (29%) 126 (32%) 150 (25%)
Age
≤54 21 (14%) 56 (14%) 107 (18%)
55–64 39 (25%) 127 (32%) 197 (33%)
65–74 64 (42%) 158 (40%) 227 (38%)
≥75 30 (19%) 57 (14%) 73 (12%)
Treatment
Preoperative 
radiotherapy
65 (42%) 196 (49%) 303 (50%)
Selective 
postoperative 
chemoradiotherapy
89 (58%) 202 (51%) 301 (50%)
Distance of distal tumour extent from anal verge
>10–15 cm 19 (12%) 54 (14%) 100 (17%)
>5–10 cm 71 (46%) 176 (45%) 336 (56%)
0–5 cm 63 (41%) 164 (42%) 163 (27%)
Missing 1 4 5
Surgical and pathological factors
Operation
Anterior resection 69 (48%) 224 (58%) 407 (71%)
Abdominoperineal 
excision
70 (48%) 152 (39%) 134 (24%)
Hartmann’s 5 (3%) 6 (2%) 20 (4%)
Other 1 (1%) 5 (1%) 9 (2%)
Missing 9 11 34
CRM
Positive 29 (19%) 47 (12%) 52 (9%)
Negative 123 (81%) 347 (88%) 543 (91%)
Missing 2 4 9
TNM stage
I 44 (29%) 95 (24%) 164 (27%)
II 41 (27%) 126 (32%) 182 (30%)
III 67 (44%) 172 (43%) 250 (41%)
IV 1 (1%) 4 (1%) 7 (1%)
Missing 1 1 1
CRM=circumferential resection margin.
Table 1: Factors associated with plane of surgery achieved
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We did a multivariate analysis with time to local 
recurrence as the outcome measure, including plane of 
surgery achieved, age, sex, WHO performance status, 
circumferential resection margin status, T stage, N stage, 
number of lymph nodes sampled, involvement of the 
anterior quadrant, type of surgery, distal extent, and 
treatment allocation. The analysis indicated that N stage, 
treatment, T stage, tumour involving the anterior 
quadrant, and plane of surgery achieved were 
independent and signiﬁ cantly associated with the risk of 
local recurrence taking into account all other variables 
(table 4). The following factors were not signiﬁ cantly 
associated with local recurrence: age (p=0·76), sex 
(p=0·71), WHO performance status (p=0·22), distal 
extent (p=0·43), type of operation (anterior resection: 
p=0·78; abdominoperineal excision: p=0·25), circum-
ferential resection margin status (p=0·79), and lymph 
nodes examined (p=0·66). When all factors were taken 
into account, circumferential resection margin status 
was not a signiﬁ cant indicator of risk of local 
recurrence.
Discussion
Preoperative short-course (5 days) radiotherapy has 
beneﬁ cial eﬀ ects on local recurrence.4–7 The results 
presented here suggest that an assessment of plane of 
surgery achieved by an appropriately trained pathologist 
can be used to identify the risk of local recurrence.
In this trial, we used the involvement of the 
circumferential resection margin to identify patients in 
the selective postoperative chemoradiotherapy group 
regarded as high risk of local recurrence. Such patients 
subsequently received adjuvant chemoradiotherapy. In 
univariate analyses, involvement of the circumferential 
resection margin predicted a higher rate of local 
recurrence and a poorer disease-free survival in both 
treatment groups. The overall circumferential resection 
margin positive rate of 11% was better than the rate of 
nearly 19% reported in a Dutch study,22 and the 
13% reported for rectal cancer in the CLASICC trial of 
laparoscopic versus open surgery.23 We also conﬁ rmed 
the high rate of local recurrence and the poor survival 
with circumferential resection margin positive tumours 
seen in previous studies.18,22,24–26 However, in multivariate 
Muscularis 
propria
Intramesorectal
HR (95%CI)*
Mesorectal
HR (95% CI)*
Overall 13% 7%, 0·48 (0·25–0·93) 4%, 0·32 (0·16–0·64)
Treatment
Preoperative radiotherapy 10% 4%, 0·52 (0·15–1·79) 1%, 0·09 (0·02–0·49)
Selective postoperative 
chemoradiotherapy
16% 10%, 0·49 (0·23–1·06) 7%, 0·48 (0·23–1·00)
Sex
Male 12% 9%, 0·57 (0·27–1·22) 4%, 0·28 (0·12–0·67)
Female 18% 5%, 0·36 (0·10–1·23) 4%, 0·35 (0·10–1·19)
Age
≤54 18% 9%, 0·22 (0·04–1·16) 4%, 0·17 (0·03–0·93)
55–64 13% 9%, 0·51 (0·15–1·73) 5%, 0·22 (0·05–0·92)
65–74 15% 7%,0·56 (0·20–1·59) 4%, 0·40 (0·13–1·18)
≥75 7% 4%, 0·37 (0·06–2·29) 5%, 0·63 (0·13–3·11)
Operation
Anterior resection 11% 7%, 0·62 (0·21–1·79) 5%, 0·58 (0·20–1·65)
Abdominoperineal excision 18% 10%, 0·41 (0·18–0·93) 3%, 0·18 (0·07–0·47)
CRM
Positive 21% 13%, 0·67 (0·19–2·38) 12%, 0·46 (0·12–1·76)
Negative 12% 7%, 0·50 (0·24–1·06) 4%, 0·33 (0·15–0·74)
TNM stage
I 8% 2%, 0·33 (0·07–1·59) 0%, 0·01 (0·00–0·10)
II 6% 2%, 0·11 (0·01–0·94) 5%, 0·78 (0·20–3·08)
III 20% 14%, 0·72 (0·33–1·56) 6%, 0·37 (0·15–0·89)
*Compared with muscularis propria. CRM=circumferential resection margin. HR=hazard ratio.  
Table 2: 3-year local recurrence rates for the plane of surgery achieved
Figure 4: Local recurrence rate (A) and disease-free survival (B) by plane of surgery achieved 
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analyses, which take into account all variables, the 
circumferential resection margin status was not 
independently associated with local recurrence.
In contrast, in both univariate and multivariate 
analyses, the plane of surgery achieved, as assessed by 
local pathologists in routine clinical practice, was 
associated with local recurrence. This result suggests 
that the plane of surgery achieved should be assessed as 
one of the main prognostic factors. Our multivariate 
analysis identiﬁ ed previously reported tumour charac-
teristics (N stage, T stage, and involvement of the 
anterior quadrant), and two treatment factors that can 
aﬀ ect outcomes (radiation treatment and the plane of 
surgery achieved), emphasising the importance of the 
surgeon and multidisciplinary team discussion.
We also showed that, for any plane of surgery achieved, 
the use of short-course preoperative radiotherapy reduces 
the local recurrence rate by more than 50%. Our data 
suggest that the plane of surgery achieved and short-course 
preoperative radiotherapy have additive eﬀ ects, indicating 
that preoperative radiotherapy is beneﬁ cial whatever 
plane of surgery is achieved. Indeed, in patients who 
received short-course preoperative radiotherapy and in 
whom a mesorectal plane resection was achieved, local 
recurrence was almost abolished.
Plane of surgery achieved did not deteriorate with 
advancing TNM stage, suggesting that it is not the late 
stage that determines the plane of resection, but the 
ability of the surgeon to stay in the mesorectal plane. 
Although we could not identify the relative contribu-
tions of the skill of the surgeon and the plane of 
surgery achieved, our results suggest that excellent 
surgery and improvement of plane of surgery achieved 
can be important in all rectal cancer surgery. These can be 
achieved through education and surgical tuition,14–16 
which are an essential aspect of the basic care of 
rectal-cancer patients. Tuition is cost eﬀ ective,27 especially 
considering the costs of treatment for disease recurrence. 
During the trial, surgeons received informal feedback on 
the planes of surgery achieved and circumferential 
resection margin positive rates. Furthermore, multi-
disciplinary teamwork was introduced in the UK, along 
with an emphasis on MRI staging. The fact that more 
tissue was removed as the trial progressed, that the 
circumferential resection margin positive rate fell 
(from 21% in 1998 to 10% in 2005), and that the frequency 
of meso rectal plane excision improved suggest that 
surgery improved, and this was not an eﬀ ect of the 
introduction of MRI.
However, the improvement in mesorectal plane 
excision was seen predominately in patients having an 
anterior resection, and less in those having an 
abdominoperineal excision. Therefore, we might need 
0·2 0·5 1·0 2·00·1
CRM –ve better CRM +ve better
Local recurrence
Muscularis propria
Intramesorectal
Mesorectal
Disease-free survival
Muscularis propria
Intramesorectal
Mesorectal
14/123
22/347
27/543
30/123
76/347
112/543
5/29
5/47
4/52
15/29
24/47
23/52
p=0·96
p=0·58
Number of events/total number
CRM –ve CRM +ve
HR (95% CI) Interaction p value
Figure 5: Eﬀ ect of circumferential resection margin on local recurrence and disease-free survival in diﬀ erent 
planes of surgery achieved 
Muscularis 
propria
Intramesorectal
HR (95%CI)*
Mesorectal
HR (95%CI)*
Overall 70% 75%, 0·82 (0·57–1·19) 79%, 0·76 (0·53–1·09)
Treatment
Preoperative radiotherapy 71% 76%, 0·83 (0·48–1·44) 82%, 0·55 (0·30–1·01)
Selective postoperative 
chemoradiotherapy
70% 74%, 0·81 (0·50–1·32) 76%, 0·94 (0·60–1·46)
Sex
Male 68% 73%, 0·83 (0·54–1·26) 80%, 0·63 (0·41–0·98)
Female 75% 79%, 0·90 (0·44–1·84) 75%, 0·98 (0·51–1·87)
Age
≤54 71% 72%, 0·88 (0·36–2·16) 84%, 0·43 (0·15–1·24)
55–64 70% 80%, 0·65 (0·31–1·37) 78%, 0·75 (0·38–1·50)
65–74 69% 75%, 0·97 (0·54–1·74) 76%, 1·02 (0·59–1·76)
≥75 69% 74%, 0·87 (0·40–2·04) 83%, 0·64 (0·30–1·53)
Operation
Anterior resection 69% 77%, 0·89 (0·51–1·57) 79%, 0·85 (0·49–1·47)
Abdominoperineal excision 71% 74%, 0·74 (0·44–1·25) 83%, 0·53 (0·30–0·95)
CRM
positive 51% 49%, 1·05 (0·55–1·99) 55%, 0·83 (0·43–1·62)
negative 74% 78%, 0·87 (0·56–1·35) 81%, 0·84 (0·55–1·28)
TNM stage
I 88% 93%, 0·60 (0·19–1·92) 95%, 0·29 (0·08–1·04)
II 66% 83%, 0·36 (0·16–0·80) 82%, 0·51 (0·25–1·05)
III 63% 62%, 1·12 (0·71–1·78) 68%, 0·97 (0·61–1·54)
*Compared with muscularis propria. CRM=circumferential resection margin. DFS=disease-free survival. HR=hazard ratio.
Table 3: 3-year disease-free survival rates for plane of surgery achieved
HR (95% CI) p value
N stage (0, 1, 2) 1·78 (1·32–2·42) <0·0001
Treatment
Preoperative radiotherapy 1·00 ..
Selective postoperative 
chemoradiotherapy
2·45 (1·45–4·17) 0·001
T stage (1, 2, 3, 4) 1·71 (1·11–2·63) 0·02
Tumour involving anterior quadrant
No 1·00 ..
Yes 1·85 (1·04–3·27) 0·04
Plane of surgery 1·37 (1·00–1·89) 0·05
HR=hazard ratio. N=nodes. T=tumour.
Table 4: Factors associated with local recurrence
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to change surgical approach for abdominoperineal 
excision to improve the surgical plane of excision and 
reduce incomplete resection of these tumours.28,29 West 
and colleagues30 have proposed that there should be 
complete resection of the levators when this operation is 
performed.
Our approach could be useful in other surgical 
operations that generate large surgical margins, such 
as the colon31 and oesophagus,32,33 and should be 
considered in the pancreas, head and neck dissections, 
and sarcoma surgery. Our approach might explain 
some of the wide variations in clinical results and 
provide a method for the improvement of cancer surgery 
at other sites. Additional prospective studies of these 
operations based on our approach are needed.
Overall, we showed an additive eﬀ ect of the plane of 
surgery achieved and short-course preoperative 
radiotherapy, leading to a 3-year local recurrence rate in 
patients receiving such radiotherapy and in whom 
surgery in the mesorectal plane is achieved of only 
1% at 3 years. We also showed that pathologists from 
80 centres, from four countries, can routinely identify 
the plane of surgery and the groups of patients with 
diﬀ erent risks of local recurrence. At present, only 
50% of rectal cancer surgery is done in the mesorectal 
plane, suggesting that a further decrease in local 
recurrence rates might be obtained by improving the 
plane of surgery achieved. Survival could be further 
improved by the use of surgical and multidisciplinary 
team training, such as those programmes completed 
(Norway,14 Stockholm,15 England, and British Columbia 
in Canada) or underway (Belgium, Jutland, Copenhagen, 
and Hong Kong). Assessment of the quality of surgery, 
for example, using the surgical plane achieved, should 
become part of the routine assessment of rectal cancers 
and could be important to improve patient outcomes.
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